Mostrar el registro sencillo del ítem

Artículo

dc.creatorPerez-Gomez, Albertoes
dc.creatorGasca-Capote, Carmenes
dc.creatorVitalle, Joanaes
dc.creatorOstos Marcos, Francisco Josées
dc.creatorSerna Gallego, Anaes
dc.creatorTrujillo-Rodriguez, Maríaes
dc.creatorRafii-El-Idrissi Benhnia, Mohammedes
dc.creatorRuiz Mateos, Ezequieles
dc.date.accessioned2022-10-28T16:04:30Z
dc.date.available2022-10-28T16:04:30Z
dc.date.issued2022
dc.identifier.citationPerez-Gomez, A., Gasca-Capote, C., Vitalle, J., Ostos Marcos, F.J., Serna Gallego, A., Trujillo-Rodriguez, M.,...,Ruiz Mateos, E. (2022). Deciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous response. Clinical and translational medicine, 12 (4), e802. https://doi.org/10.1002/ctm2.802.
dc.identifier.issn2001-1326es
dc.identifier.urihttps://hdl.handle.net/11441/138485
dc.description.abstractSARS-CoV-2 specific T-cell response has been associated with disease severity, immune memory and heterologous response to endemic coronaviruses. However, an integrative approach combining a comprehensive analysis of the quality of SARS-CoV-2 specific T-cell response with antibody levels in these three scenarios is needed. In the present study, we found that, in acute infection, while mild disease was associated with high T-cell polyfunctionality biased to IL-2 production and inversely correlated with anti-S IgG levels, combinations only including IFN-γ with the absence of perforin production predominated in severe disease. Seven months after infection, both non-hospitalised and previously hospitalised patients presented robust anti-S IgG levels and SARS-CoV-2 specific T-cell response. In addition, only previously hospitalised patients showed a T-cell exhaustion profile. Finally, combinations including IL-2 in response to S protein of endemic coronaviruses were the ones associated with SARS-CoV-2 S-specific T-cell response in pre-COVID-19 healthy donors’ samples. These results could have implications for protective immunity against SARS-CoV-2 and recurrent COVID-19 and may help for the design of new prototypes and boosting vaccine strategies.es
dc.formatapplication/pdfes
dc.format.extent21 p.es
dc.language.isoenges
dc.publisherWILEYes
dc.relation.ispartofClinical and translational medicine, 12 (4), e802.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCOVID-19es
dc.subjectEndemic coronaviruseses
dc.subjectIL-2es
dc.subjectNucleocapsides
dc.subjectPolyfunctionalityes
dc.subjectSARS-CoV-2es
dc.subjectSpikees
dc.subjectT-cell responsees
dc.titleDeciphering the quality of SARS-CoV-2 specific T-cell response associated with disease severity, immune memory and heterologous responsees
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Bioquímica Médica y Biología Molecular e Inmunologíaes
dc.relation.projectIDRH-0037-2020es
dc.relation.projectIDPI19/01127es
dc.relation.publisherversionhttps://onlinelibrary.wiley.com/doi/10.1002/ctm2.802es
dc.identifier.doi10.1002/ctm2.802es
dc.journaltitleClinical and translational medicinees
dc.publication.volumen12es
dc.publication.issue4es
dc.publication.initialPagee802es
dc.contributor.funderInstituto de Salud Carlos IIIes
dc.contributor.funderEuropean Commission (EC). Fondo Europeo de Desarrollo Regional (FEDER)es
dc.contributor.funderConsejería de Salud, Junta de Andalucíaes
dc.contributor.funderConsejeria de Transformacion Economica, Industria, Conocimiento y Universidades, Junta de Andaluciaes

FicherosTamañoFormatoVerDescripción
Deciphering the quality.pdf5.576MbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional